Deery W J, Rani C S
Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
Endocrinology. 1991 Jun;128(6):2967-75. doi: 10.1210/endo-128-6-2967.
The mechanism and site(s) of the defect responsible for desensitization to hormone stimulation of adenylyl cyclase (AC) vary with cell type. Plasma membrane preparations were assayed after treatment of primary cultured dog thyroid cells to determine the role of the TSH receptor, stimulatory and inhibitory guanine nucleotide binding proteins (Gs and Gi), and catalytic unit in AC desensitization. Exposure of cells to TSH or the phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), caused time dependent decreases in TSH-stimulated AC and [125I]TSH binding with approximately 50% decreases seen after 18 h; Bt2cAMP was unable to reproduce the TSH effect. Whereas TSH treatment caused concomitant decreases (approximately 25%) in both cyclase activity and [125I]TSH binding after 2 h, TPA treatment decreased AC activity after 6 h and binding only after 18 h. The protein kinase C inhibitor, H-7, prevented TPA-induced but not TSH-induced effects on AC and hormone binding. Membrane AC activation by cholera toxin or forskolin was not altered by 18 h pretreatment of cells with TSH or TPA, indicating that these agents had no apparent effect on intrinsic functionality of either Gs or the catalytic unit. TSH or TPA pretreatment of cells reduced subsequent toxin-mediated AD[32P]-ribosylation of Gs and Gi in isolated membranes. However, the TSH- and TPA-induced decreases in AD[32P]-ribosylation and desensitization do not appear to be due to endogenous ribosylation of G proteins, since treatment of cells with pertussis toxin, for example, to endogenously ribosylate Gi, both increased TSH-stimulated AC activity and failed to affect the ability of TSH or TPA to desensitize. Thus, in this system, although specific hormone-induced AC desensitization and receptor down-regulation conform to several aspects of classic homologous processes, similar effects are also induced by a nonreceptor (phorbol ester) pathway; desensitization, however, can precede down-regulation, possibly due to receptor-Gs uncoupling.
导致对腺苷酸环化酶(AC)激素刺激脱敏的缺陷机制和部位因细胞类型而异。在对原代培养的犬甲状腺细胞进行处理后,对质膜制剂进行检测,以确定促甲状腺激素(TSH)受体、刺激性和抑制性鸟嘌呤核苷酸结合蛋白(Gs和Gi)以及催化单位在AC脱敏中的作用。将细胞暴露于TSH或佛波酯12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)会导致TSH刺激的AC和[125I]TSH结合随时间下降,18小时后约下降50%;Bt2cAMP无法重现TSH的作用。TSH处理2小时后,环化酶活性和[125I]TSH结合同时下降(约25%),而TPA处理6小时后AC活性下降,18小时后结合才下降。蛋白激酶C抑制剂H - 7可阻止TPA诱导的对AC和激素结合的影响,但不能阻止TSH诱导的影响。用TSH或TPA对细胞进行18小时预处理后,霍乱毒素或福斯高林对膜AC的激活未改变,这表明这些试剂对Gs或催化单位的内在功能没有明显影响。对细胞进行TSH或TPA预处理会降低随后毒素介导的分离膜中Gs和Gi的AD[32P] - 核糖基化。然而,TSH和TPA诱导的AD[32P] - 核糖基化下降和脱敏似乎不是由于G蛋白的内源性核糖基化,因为用百日咳毒素处理细胞以使Gi内源性核糖基化,既增加了TSH刺激的AC活性,又未能影响TSH或TPA诱导脱敏的能力。因此,在这个系统中,尽管特定激素诱导的AC脱敏和受体下调符合经典同源过程的几个方面,但非受体(佛波酯)途径也能诱导类似的效应;然而,脱敏可能先于下调,这可能是由于受体 - Gs解偶联。